| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |